BB BIOTECH AGBB BIOTECH AGBB BIOTECH AG

BB BIOTECH AG

No trades
See on Supercharts

Key stats

Assets under management (AUM)
Fund flows (1Y)
Dividend yield (indicated)
4.81%
Discount/Premium to NAV

About BB BIOTECH AG

ISIN
CH0038389992
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.